申请人:Hoechst Aktiengesellschaft
公开号:US05169841A1
公开(公告)日:1992-12-08
The invention relates to compounds of the formula 1 ##STR1## in which A.sup.1 denotes a radical of the formulae ##STR2## A.sup.2 is absent or represents a radical of the formula ##STR3## R.sup.2, R.sup.3 and R.sup.4 are as defined in the specification, and X and Y, independently of one another, represent --O-- or --NR.sup.13 --, and to the salts thereof. Also described is a process for the preparation of the compounds of the formula 1, corresponding pharmaceutical products, and the use thereof as medicines, and intermediates for the preparation of these compounds.
本发明涉及式1的化合物:##STR1## 其中,A.sup.1表示式的基团:##STR2## A.sup.2不存在或表示式的基团:##STR3## R.sup.2、R.sup.3和R.sup.4如规范中所定义,而X和Y独立地表示--O--或--NR.sup.13 --,以及其盐。还描述了制备式1化合物的过程,相应的药物制品以及其用作药物的用途以及制备这些化合物的中间体。